QNTM - Quantum BioPharma Ltd. Qarzning balans kapitallashuviga nisbati

Quantum BioPharma Ltd. (QNTM) grafik logotipi

Quantum BioPharma Ltd dori vositalarini ishlab chiqish jarayonida uglerod izini minimallashtirish uchun ESG standartlarini joriy qilmoqda. Qarzning kitob kapitalizatsiyasi nisbatining dinamikasi moliyaviy strategiyani aniq tasdiqlaydi, bunda 0.12 eng so'nggi metrika darajasini ifodalaydi. Barqarorlik nisha ingredientlariga bo'lgan doimiy talab bilan ta'minlanmoqda, asosiy ishlanmalar esa tashqi laboratoriya hamkorlariga topshirilgan.

QNTM (Quantum BioPharma Corp) Qarzning balans qiymatiga nisbati tarixi 16.08.2024dan 27.10.2026gacha

Quantum BioPharma Ltd. (QNTM) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Quantum BioPharma Ltd|QNTM - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Quantum BioPharma Corp|QNTM - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Quantum BioPharma|QNTM - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati quantumbiopharma.com|QNTM - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Quantum BioPharma Ltd|QNTM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Quantum BioPharma Limited|QNTM - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Quantum BioPharma Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:QNTM Quantum BioPharma Ltd
Quantum BioPharma Limited asosiy tovari

Qimmat neyroprotektiv ishlanmalarga investitsiya kiritadigan Quantum BioPharma Ltd (QNTM) uchun leverajni monitoring qilish juda muhimdir. Ushbu metrika barcha majburiyatlarning kompaniya kapitaliga nisbatan hajmini o'lchaydi. Qarz majburiyatlarining balans kapitaliga nisbatidagi ushbu ko'rsatkichi moliyaviy hisobotlarni kutmasdan, moliyaviy barqarorlikni real vaqt rejimida baholash imkonini beradi. Grafikdagi yuqoriga yo'nalgan tendentsiya bankrotlik xatarlarining ortishidan dalolat beradi, barqaror metrika darajasi esa emitentning o'z ilmiy salohiyatini saqlab qolish qobiliyatini tasdiqlaydi.

Quantum BioPharma Ltd raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|SXTC (China SXT Pharmaceuticals, Inc.) - Qarzning balans kapitallashuviga nisbati|EPRX - Qarzning sof aktivlarga nisbati|BioHarvest - Qarzning balans qiymatiga nisbati|EXOZ - Balans kapitallashuviga qarzlar|ORMP: Balans kapitallashuviga qarzlar|ENTX (Entera Bio) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati MindWalk Holdings Inc. (HYFT)|Qarzning balans qiymatiga nisbati ABVC BioPharma Inc. (ABVC)|Qarzning balans qiymatiga nisbati Cumberland Pharma|Qarzning balans kapitaliga nisbati FibroGen Corporation FGEN|Qarzning balans qiymatiga nisbati TELO (Telomir Pharmaceuticals)|Rani Therapeutics Holdings - Balans kapitallashuviga qarzlar|SNYR: Qarzning balans kapitallashuviga nisbati|Rallybio Corporation (RLYB) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati lexariabioscience.com LEXX|Pulmatrix Corporation (PULM) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Pheton Holdings Limited|Qarzning balans kapitallashuviga nisbati Aptorum|LYRA (Lyra Therapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar IBO (Impact BioMedical, Inc.)|TNFA: Qarzning balans kapitallashuviga nisbati|cbdMD Inc. - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati PainReform Ltd.|CYTO - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Lipella Pharmaceuticals, Inc. LIPO|OptiNose Inc (OPTN) - Qarzning sof aktivlarga nisbati|PIRS (Pieris) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar PROC|Petros Pharmaceuticals (PTPI) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati QLI (qlsyy.net)|ACELYRIN - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati TFF Pharmaceuticals Inc. TFFP